8,921 Shares in Rentokil Initial PLC $RTO Bought by Callan Family Office LLC

Callan Family Office LLC acquired a new position in shares of Rentokil Initial PLC (NYSE:RTOFree Report) in the second quarter, Holdings Channel reports. The firm acquired 8,921 shares of the company’s stock, valued at approximately $214,000.

Other hedge funds have also recently made changes to their positions in the company. Parallel Advisors LLC lifted its stake in shares of Rentokil Initial by 416.9% during the 2nd quarter. Parallel Advisors LLC now owns 1,132 shares of the company’s stock worth $27,000 after purchasing an additional 913 shares during the last quarter. Brooklyn Investment Group lifted its stake in shares of Rentokil Initial by 668.3% during the 1st quarter. Brooklyn Investment Group now owns 1,598 shares of the company’s stock worth $37,000 after purchasing an additional 1,390 shares during the last quarter. State of Wyoming purchased a new stake in shares of Rentokil Initial during the 1st quarter worth $46,000. Cape Investment Advisory Inc. lifted its stake in shares of Rentokil Initial by 67.4% during the 1st quarter. Cape Investment Advisory Inc. now owns 2,519 shares of the company’s stock worth $58,000 after purchasing an additional 1,014 shares during the last quarter. Finally, Cromwell Holdings LLC lifted its stake in shares of Rentokil Initial by 397.3% during the 2nd quarter. Cromwell Holdings LLC now owns 2,546 shares of the company’s stock worth $61,000 after purchasing an additional 2,034 shares during the last quarter. 9.91% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

RTO has been the subject of a number of research analyst reports. Zacks Research upgraded Rentokil Initial from a “strong sell” rating to a “hold” rating in a research note on Friday, October 10th. Jefferies Financial Group upgraded Rentokil Initial to a “strong-buy” rating in a research note on Wednesday, October 8th. Berenberg Bank upgraded Rentokil Initial to a “strong sell” rating in a research note on Monday, September 29th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Rentokil Initial in a research note on Wednesday, October 8th. Finally, Sanford C. Bernstein upgraded Rentokil Initial from an “underperform” rating to an “outperform” rating in a research note on Tuesday, October 7th. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy”.

Get Our Latest Stock Report on RTO

Rentokil Initial Stock Up 0.1%

Shares of NYSE:RTO opened at $26.71 on Friday. Rentokil Initial PLC has a 52-week low of $19.60 and a 52-week high of $27.96. The stock has a market cap of $13.49 billion, a price-to-earnings ratio of 17.69, a PEG ratio of 4.64 and a beta of 0.95. The business has a 50-day moving average price of $25.26 and a 200-day moving average price of $24.02.

Rentokil Initial Cuts Dividend

The business also recently announced a semi-annual dividend, which was paid on Tuesday, September 23rd. Investors of record on Friday, August 15th were issued a dividend of $0.2738 per share. This represents a yield of 240.0%. The ex-dividend date of this dividend was Friday, August 15th. Rentokil Initial’s dividend payout ratio (DPR) is 21.85%.

About Rentokil Initial

(Free Report)

Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.

Featured Articles

Want to see what other hedge funds are holding RTO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rentokil Initial PLC (NYSE:RTOFree Report).

Institutional Ownership by Quarter for Rentokil Initial (NYSE:RTO)

Receive News & Ratings for Rentokil Initial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rentokil Initial and related companies with MarketBeat.com's FREE daily email newsletter.